The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...
A federal court rejected Novartis Pharmaceuticals’, a unit of Novartis AG (NYSE:NVS) legal challenge to the Medicare Drug ...
The Inflation Reduction Act of 2022 marked a significant shift in US health care policy, granting the Centers for Medicare and Medicaid Services (CMS) the authority to establish a program to negotiate ...
Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...
Money Talks News on MSN1d
Medicare's Latest Drug Price Deal Could Save Billions for SeniorsMedicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic.
The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.
The court ruled that Novartis is not legally compelled to participate in the Medicare Drug Price Negotiation Program. The decision reaffirmed that the program does not constitute excessive fines ...
New York Post on MSN7d
House lawmakers rip ‘middlemen’ over high drug prices – despite welcoming donations from industryRecords show that drug companies gave nearly $75,000 to the top Republican and Democrat on a committee investigating them.
At least three government lawyers working on defending a major Biden-era drug pricing law were laid off in mass cuts across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback